Ann: Update on hemp-derived CBD clinical trials, page-11

First 11 Last

Share
Profile

Follow
HempCFO

1,578 Posts.

237

14/07/20

00:41

Post #: 45839531
Share

Originally posted by GTFC: ↑

My own thoughts are he may be partially right as the trials are not just using CBD, they are using an Ananda Full Spectrum product, which is a combination of CBD and a whole range of other cannabinoids, terpenes and other stuff. Sure some other cannabinoid companies will be able to almost replicate the Ananda Full Spectrum product, but it will be a ball ache for companies choosing to do so and I would also guess that not all companies out there have the type of chromatography machine that can isolate all the cannabinoids needed in the recipe, Even if another company could replicate It, the additional cost of doing so would put them at a disadvantage and now that Ananada has managed to get their products in so many dispensaries, it would be a difficult job to get them displaced by a brand that did not participate in the study. I may be wrong, but it is my opinion.
Another thing which surprises me about the studies is their focus, as previous EOF shareholder updates have made reference to the initial trial being one using THCV for type 2 diabetes. Could it be that they are going for the low hanging fruit first.

Expand

And with that, I’m gonna crack a beer and light up a “full spectrum” paper based delivery system.

Nothing new is getting invented here. And mine has THC too! “Full spectrum” is just my joint with the fun removed.

EOF Price at posting: $2.36 Sentiment: Hold Disclosure: Held
3 Upvote

1 Great analysis

Reply

Top Stories

RAD

Radiopharm extends radioimmunotherapy trial to 5 more cancer types

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

PAM

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

SGP

Things finally 'looking different' for up-and-down Hot Stock tip Stockland

First 11 Last

Add EOF (ASX) to my watchlist

(20min delay)
Last 4.0¢		Change 0.000(0.00%)		Mkt cap ! $15.15M

Open	High	Low	Value	Volume
4.0¢	4.2¢	4.0¢	$708	17.32K

Buyers (Bids)

No.	Vol.	Price($)
1	6347	4.0¢

Sellers (Offers)

Price($)	Vol.	No.
4.1¢	18623	1

View Market Depth

No.	Vol.	Price($)
1	6347	0.040
2	165625	0.032
1	9000	0.028
1	40000	0.025
1	47665	0.021

Price($)	Vol.	No.
0.041	18623	1
0.042	12889	1
0.043	17995	1
0.045	1000	1
0.046	50000	1

Last trade - 15.33pm 19/11/2024 (20 minute delay)

EOF (ASX) Chart

Ann: Update on hemp-derived CBD clinical trials, page-11

Radiopharm extends radioimmunotherapy trial to 5 more cancer types

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Things finally 'looking different' for up-and-down Hot Stock tip Stockland

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Update on hemp-derived CBD clinical trials, page-11

Top Stories

Radiopharm extends radioimmunotherapy trial to 5 more cancer types

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Things finally 'looking different' for up-and-down Hot Stock tip Stockland

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News